Vanguard Group
EVLO

Vanguard Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-357,711
Closed -$1.4M 4593
2023
Q3
$1.4M Buy
357,711
+201,815
+129% +$791K ﹤0.01% 3718
2023
Q2
$507K Sell
155,896
-3,012,479
-95% -$9.79M ﹤0.01% 4118
2023
Q1
$573K Hold
3,168,375
﹤0.01% 4090
2022
Q4
$5.1M Sell
3,168,375
-54,045
-2% -$87K ﹤0.01% 3298
2022
Q3
$6.74M Buy
3,222,420
+1,862,098
+137% +$3.89M ﹤0.01% 3155
2022
Q2
$2.87M Sell
1,360,322
-184,196
-12% -$389K ﹤0.01% 3646
2022
Q1
$5.24M Buy
1,544,518
+132,702
+9% +$450K ﹤0.01% 3505
2021
Q4
$8.57M Sell
1,411,816
-84,071
-6% -$510K ﹤0.01% 3307
2021
Q3
$10.5M Buy
1,495,887
+19,103
+1% +$134K ﹤0.01% 3213
2021
Q2
$20.3M Buy
1,476,784
+123,560
+9% +$1.7M ﹤0.01% 2836
2021
Q1
$14.5M Buy
1,353,224
+199,158
+17% +$2.13M ﹤0.01% 2954
2020
Q4
$14M Buy
1,154,066
+267,106
+30% +$3.23M ﹤0.01% 2821
2020
Q3
$4.67M Buy
886,960
+13,906
+2% +$73.3K ﹤0.01% 3182
2020
Q2
$4.28M Buy
873,054
+446,342
+105% +$2.19M ﹤0.01% 3171
2020
Q1
$1.6M Buy
426,712
+944
+0.2% +$3.54K ﹤0.01% 3358
2019
Q4
$1.73M Sell
425,768
-2,147
-0.5% -$8.72K ﹤0.01% 3490
2019
Q3
$2.61M Sell
427,915
-7,420
-2% -$45.3K ﹤0.01% 3363
2019
Q2
$3.91M Buy
435,335
+3,685
+0.9% +$33.1K ﹤0.01% 3253
2019
Q1
$3.45M Buy
431,650
+117,781
+38% +$942K ﹤0.01% 3278
2018
Q4
$4.08M Buy
313,869
+74,077
+31% +$964K ﹤0.01% 3156
2018
Q3
$2.92M Buy
239,792
+172,804
+258% +$2.1M ﹤0.01% 3408
2018
Q2
$790K Buy
+66,988
New +$790K ﹤0.01% 3745